Creative BioMart to Host Webinar on AI-Driven CDMO Solutions for Advanced Protein Expression and Antibody Drug Development

Creative BioMart will host an online webinar, “AI-Driven CDMO Solutions for Advanced Protein Expression and Antibody Drug Development,” on August 26, 2026, at 3 PM EDT / 9 PM CEST. The session will introduce AI-driven approaches for protein expression and antibody development, including 3D structure prediction, affinity maturation, immunogenicity risk assessment, and de novo antibody design.

The upcoming webinar follows Creative BioMart’s July 22 session, “Advanced Solutions for Membrane Protein Expression, Purification and Structural Analysis,” which focused on strategies for producing, purifying, and structurally analyzing challenging membrane proteins. The July session covered expression across bacterial, yeast, insect, mammalian, and cell-free systems, as well as protein reconstitution in proteoliposomes, nanodiscs, and virus-like particles. It also featured case studies involving full-length transmembrane proteins such as CCR6 and CCR8. The webinar recording is now available for researchers who would like to review the session.

Building on that previous discussion of advanced protein production, the August webinar will turn to AI-driven approaches that can be incorporated into protein and antibody development workflows. The session will cover 3D structure prediction, affinity maturation, immunogenicity risk assessment, and de novo antibody design, together with Creative BioMart’s broader protein expression and development capabilities.

Creative BioMart’s platform combines computational approaches with experimental development and production capabilities. Its services include scalable mammalian and microbial expression systems, GMP-compliant facilities, and analytical technologies including LC-MS, iCIEF, CE-SDS, and qPCR. The company also supports applications involving membrane proteins, recombinant antibodies, and GMP-grade manufacturing.

“We were pleased to bring researchers together for our July webinar on membrane protein expression, purification, and structural analysis, and we look forward to welcoming more researchers to our August session,” said Linna, the chief marketing staff at Creative BioMart. “This webinar will focus on AI-driven approaches for protein and antibody development and provide an opportunity to learn more about how these technologies can be incorporated into development workflows.”

Researchers and industry professionals interested in AI-assisted protein expression, protein engineering, antibody development, and related CDMO solutions are invited to join the August webinar.  Registration and additional information are available through Creative BioMart’s webinar page: https://www.creativebiomart.net/ai-driven-cdmo-solutions-for-advanced-protein-expression-and-antibody-drug-development_2496.htm.